BUZZ-Pennant Group jumps after Truist upgrades on growth outlook
I'm PortAI, I can summarize articles.
Pennant Group's shares rose 3.22% after Truist Securities upgraded the stock to "buy" from "hold," citing strong operating trends and reduced reimbursement risk due to favorable 2026 Medicare rules. The brokerage raised the price target to $34, indicating a 19.7% upside. Pennant's acquisition integration is progressing well, with margins expected to normalize. All brokerages rate the stock as "strong buy" or "buy," with a median price target of $35.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments